Evidence map›Paper›PMID 24145379›Full record

ArticleMolecular psychiatry2014

Response to 'Predicting the diagnosis of autism spectrum disorder using gene pathway analysis'.

E B Robinson, D Howrigan, J Yang, S Ripke, V Anttila, L E Duncan, L Jostins, J C Barrett, S E Medland, D G MacArthur and 8 more

Abstract readLetterComment
In one paragraph

Article in Molecular psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Bio-collections in autism research.Molecular autism · 2017
    Review
  4. Review
  5. Response to Robinson et al.Molecular psychiatry · 2015
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

E B Robinson1] Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA [2] Department of Medicine, Harvard Medical School, Boston, MA, USA [3] Medical and Population Genetics Program, Broad Institute for Harvard and MIT, Cambridge, MA, USA.
D Howrigan1] Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA [2] Department of Medicine, Harvard Medical School, Boston, MA, USA [3] Medical and Population Genetics Program, Broad Institute for Harvard and MIT, Cambridge, MA, USA.
J Yang1] The University of Queensland, Queensland Brain Institute, Brisbane, QLD, Australia [2] The Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
S Ripke1] Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA [2] Department of Medicine, Harvard Medical School, Boston, MA, USA [3] Medical and Population Genetics Program, Broad Institute for Harvard and MIT, Cambridge, MA, USA [4] Stanley Center for Psychiatric Research, Broad Institute for Harvard and MIT, Cambridge, MA, USA.
V Anttila1] Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA [2] Department of Medicine, Harvard Medical School, Boston, MA, USA [3] Medical and Population Genetics Program, Broad Institute for Harvard and MIT, Cambridge, MA, USA [4] Stanley Center for Psychiatric Research, Broad Institute for Harvard and MIT, Cambridge, MA, USA.
L E Duncan1] Medical and Population Genetics Program, Broad Institute for Harvard and MIT, Cambridge, MA, USA [2] Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA [3] Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts, General Hospital, Boston, MA, USA [4] Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
L JostinsWellcome Trust Sanger Institute, Cambridge, UK.
J C BarrettWellcome Trust Sanger Institute, Cambridge, UK.
S E MedlandQueensland Institute of Medical Research, Brisbane, QLD, Australia.
D G MacArthur1] Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA [2] Department of Medicine, Harvard Medical School, Boston, MA, USA [3] Medical and Population Genetics Program, Broad Institute for Harvard and MIT, Cambridge, MA, USA.
G BreenSocial Genetic and Developmental Psychiatry Center, Institute of Psychiatry, King's College London, London, UK.
M C O'DonovanMRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University School of Medicine, Cardiff, UK.
N R Wray1] The University of Queensland, Queensland Brain Institute, Brisbane, QLD, Australia [2] The Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
B DevlinDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
M J Daly1] Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA [2] Department of Medicine, Harvard Medical School, Boston, MA, USA [3] Medical and Population Genetics Program, Broad Institute for Harvard and MIT, Cambridge, MA, USA [4] Stanley Center for Psychiatric Research, Broad Institute for Harvard and MIT, Cambridge, MA, USA.
P M Visscher1] The University of Queensland, Queensland Brain Institute, Brisbane, QLD, Australia [2] The Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
P F SullivanDepartment of Genetics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
B M Neale1] Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA [2] Department of Medicine, Harvard Medical School, Boston, MA, USA [3] Medical and Population Genetics Program, Broad Institute for Harvard and MIT, Cambridge, MA, USA [4] Stanley Center for Psychiatric Research, Broad Institute for Harvard and MIT, Cambridge, MA, USA.

Funding

Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
Genome-Wide Association Analysis in Essential Hypertension (FEHGAS study)R01HL086694 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ARAVINDA CHAKRAVARTI · 2007 to 2026
$21.2M
Genome-Wide Association for Loci Influencing CHD and Other Heart, Lung and BloodR01HL087641 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A. · 2006 to 2008
$3.7M
GWA for Gene-Environment Interaction Effects Influencing CHDU01HG004402 · NHGRI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A. · 2007 to 2009
$1.6M
Medical Research Council G0800509Medical Research Council G0801418Medical Research Council MR/L010305/1NCATS NIH HHS UL1 TR001079NCRR NIH HHS UL1 RR025005NHGRI NIH HHS U01 HG004402NHLBI NIH HHS HHSN268201100005CNHLBI NIH HHS HHSN268201100006CNHLBI NIH HHS HHSN268201100007CNHLBI NIH HHS HHSN268201100008CNHLBI NIH HHS HHSN268201100009CNHLBI NIH HHS HHSN268201100010CNHLBI NIH HHS HHSN268201100011CNHLBI NIH HHS HHSN268201100012CNHLBI NIH HHS R01 HL086694NHLBI NIH HHS R01 HL087641
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Child Development Disorders, PervasiveFemaleGene Regulatory NetworksGenetic Predisposition to DiseaseHumansMalePolymorphism, Single Nucleotide

Identifiers

PMID24145379
PMCPMC4113933

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.